Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Background The COVID-19 pandemic has disrupted cervical cancer screening services.
Assuming increases to screening capacity are unrealistic, we propose two recovery …

Introduction In England, routine invitations for cervical screening were reduced between
April 2020 and June 2020 due to the COVID-19 pandemic. We quantify the impact of COVID …

Background The COVID-19 pandemic threatens the impact of cervical cancer screening and
global cervical cancer elimination goals. As cervical cancer screening programmes were …

The COVID-19 pandemic has a major impact on a wide range of health outcomes.
Disruptions of elective health services related to cervical screening, management of …

COVID-19 has disrupted cervical screening in several countries, due to a range of policy-,
health-service and participant-related factors. Using three well-established models of …

Objectives To quantify the secondary impacts of the COVID-19 pandemic disruptions to
cervical cancer screening in the United States, stratified by step in the screening process …

Cervical cancer remains the fourth most common cancer in women, with 85% of deaths
occurring in LMICs. Despite the existence of effective vaccine and screening tools, efforts to …

Discussion KPSC patient data provided an opportunity to evaluate the impact of the COVID-
19 pandemic on cervical cancer screening because of the availability of a large volume of …

Background Cervical cancer screening coverage is a key monitoring indicator of the WHO
cervical cancer elimination plan. We present global, regional, and national cervical …